Primary Intestinal Non-Hodgkin's Lymphoma and Epstein-Barr Virus: High Frequency of EBV-Infection in T-cell Lymphomas of Mexican Origin

References

• Epstein M. A., Achong B. G., Barr Y. M. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964; i: 702
   Web of Science ®Google Scholar
• Wu T., Mann R. B., Epstein J., et al. Abundant expression of EBER 1 small nuclear RNA in nasopharyngeal carcinoma: a morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed paraffin-embedded carcinoma specimens. Am. J. Pathol. 1991; 138: 1461–1469
   PubMed Web of Science ®Google Scholar
• Mueller N., Evans A., Harris N., et al. Hodgkin's disease and Epstein-Barr virus. N. Engl. J. Med. 1989; 320: 689–695
   PubMed Web of Science ®Google Scholar
• Staal S. P., Ambinder R., Beschorner W. E., Hayward G. S., Mann R. A survey of Epstein-Barr virus DNA in lymphoid tissue. Frequent detection in Hodgkin's disease. Am. J. Pathol 1989; 91: 1–5
   Web of Science ®Google Scholar
• Herbst H., Niedobitek G., Kneba M., et al. High incidence of Epstein-Barr virus genomes in Hodgkin's disease. Am. J. Pathol. 1990; 137: 13–18
   PubMed Web of Science ®Google Scholar
• Weiss L. M., Movahed L. A., Warnke R. A., Sklar J. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N. Engl. J. Med. 1989; 320: 502–506
   PubMed Web of Science ®Google Scholar
• Beral V., Peterman T., Berkelman R., Jaffe H. Aids-associated non-Hodgkin's lymphoma. Lancet 1991; 337: 805–809
   PubMed Web of Science ®Google Scholar
• Craig F. E., Gulley M. L., Banks P. M. Posttransplantation lymphoproliferative disorders. Am. J. Clin. Pathol. 1993; 99: 265–271
   PubMed Web of Science ®Google Scholar
• Hamilton-Dutoit S. J., Pallesen G. A survey of Epstein-Barr virus gene expression in sporadic non-Hodgkin's lymphomas. Am. J. Pathol. 1992; 140: 1315–1325
   PubMed Web of Science ®Google Scholar
• D'Amore F., Johansen P., Houmand A., Weisenburger D. D., Mortensen L. S. Epstein-Barr virus genome in non-Hodgkin's lymphoma occurring in immunocompetent patients: Highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Blood 1996; 87: 1045–1055
   PubMed Web of Science ®Google Scholar
• Jones J. F., Shurin S., Abramowsky C., et al. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N. Engl. J. Med. 1988; 318: 733–741
   PubMed Web of Science ®Google Scholar
• Su I. J., Hsieh H. C., Lin K. H., et al. Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: A clinicopathologic and molecular analysis. Blood 1991; 77: 799–808
   PubMed Web of Science ®Google Scholar
• Korbjuhn P., Anagnostopoulos I., Hummel M., et al. Frequent latent Epstein-Barr virus infection of neoplastic T-cells and bystander B-cells in human immunodeficiency virus-negative European peripheral pleomorphic T-cell lymphomas. Blood 1993; 82: 217–223
   PubMed Web of Science ®Google Scholar
• Zhou X. G., Hamilton-Dutoit S. J., Yan Q. H., Pallesen G. High frequency of Epstein-Barr virus in Chinese peripheral T-cell lymphoma. Histopathology 1994; 24: 115–122
   PubMed Web of Science ®Google Scholar
• Deamant F. D., AlbÜJar P. F., Chen Y.-Y., Weiss L. M. Epstein-Barr virus distribution in nonneoplastic lymph nodes. Mod. Pathol 1993; 6: 729–732
   PubMed Web of Science ®Google Scholar
• Tsoukas C. D., Lambris J. D. Expression of EBV/C3d receptors on T-cells: biological significance. Immunol. Today 1993; 14: 56–59
   PubMedGoogle Scholar
• Groux H., Cottrez F., Montpellier C., et al. Isolation and characterization of transformed human T-cell lines infected by Epstein-Barr virus. Blood 1997; 89: 4521–4530
   PubMed Web of Science ®Google Scholar
• De Bruin P. C., Jiwa M., Ouedejans J. J., et al. Presence of Epstein-Barr virus in extranodal T-cell lymphomas: differences in relation to site. Blood 1994; 83: 1612–1618
   PubMed Web of Science ®Google Scholar
• Kanavaros P., De Bruin P. C., Briere J., Meijer C. J. L. M., Gaulard P. Epstein-Barr virus (EBV) in extranodal T-cell non-Hodgkin's lymphoma (T-NHL). Identification of nasal T-NHL as a distinct clinicopathological entity associated with EBV. Leukem. Lymphoma 1995; 18: 27–34
   PubMed Web of Science ®Google Scholar
• Harabuchi Y., Yamanaka N., Kataura A., et al. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 1990; 335: 128–130
   PubMed Web of Science ®Google Scholar
• Arber D. A., Weiss L. M., Abujar P. F., Chen Y. Y., Jaffe E. S. Nasal lymphomas in Peru. High incidence of T-cell immunophenotype and Epstein-Barr virus infection. Am. J. Surg. Pathol. 1993; 17: 392–399
   PubMed Web of Science ®Google Scholar
• Borisch B., Hennig I., Laeng R. H., Waelti E. R., Kraft R., Laissue J. Association of the subtype 2 of the Epstein-Barr virus with T-cell non-Hodgkin's lymphoma of the midline granuloma type. Blood 1993; 82: 858–864
   PubMed Web of Science ®Google Scholar
• Chan J. K. C., Yip T. T. C., Tsang W. Y. W., et al. Detection of Epstein-Barr viral RNA in malignant lymphomas of the upper aerodigestive tract. Am. J. Surg. Pathol. 1994; 18: 938–946
   PubMed Web of Science ®Google Scholar
• Kanavaros P., Lescs M. C., BriÈRe J., et al. Nasal T-cell lymphoma: A clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 1993; 81: 2688–2695
   PubMed Web of Science ®Google Scholar
• Medeiros J. L., Jaffe E. S., Chen Y.-Y., Weiss L. M. Localization of Epstein-Barr viral genomes in angio-centric immunoproliferative lesions. Am. J. Surg. Pathol. 1992; 16: 439–447
   PubMed Web of Science ®Google Scholar
• De Bruin P. C., Jiwa N. M., Van der valk P., et al. Detection of Epstein-Barr virus nucleic acid sequences and protein in nodal T-cell lymphomas: relation between latent membrane protein-1 positivity and clinical course. Histopathology 1993; 23: 509–518
   PubMed Web of Science ®Google Scholar
• Sabourin J. C., Kanavaros P., BriÈRe J., et al. Epstein-Barr virus genomes and EBV-encoded latent membrane protein in pulmonary lymphomas occurring in non-immuno-compromised patients. Am. J. Surg. Pathol. 1993; 178: 995–1002
   Web of Science ®Google Scholar
• Anwar N., Kingma D. W., Bloch A. R., et al. The investigation of Epstein-Barr viral sequences in 41 cases of Burkitt's lymphoma from Egypt. Cancer 1995; 76: 1245–1252
   PubMed Web of Science ®Google Scholar
• Chen W.-G., Chen Y.-Y., Bacchi M. M., Bacchi C. E., Alvarenga M., Weiss L. M. Genotyping of Epstein-Barr virus in Brazilian Burkitt's lymphoma and reactive lymphoid tissue. Type A with a high prevalence of deletions within the latent membrane protein gene. Am. J. Pathol. 1996; 148: 17–23
   PubMed Web of Science ®Google Scholar
• Gutierrez M. I., Bhatia K., Barriga F., et al. Molecular epidemiology of Burkitt's lymphoma from South America: differences in breakpoint location and Epstein-Barr virus association from tumors in other world regions. Blood 1992; 79: 3261–3266
   PubMed Web of Science ®Google Scholar
• Hummel M., Anagnostopoulos I., Korbjuhn P., Stein H. Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low-and high-grade types. J. Pathol. 1995; 175: 263–271
   PubMed Web of Science ®Google Scholar
• Mansoor A., Stetler-Stevenson M., Li R. Z., et al. Prevalence of Epstein-Barr viral sequences and EBV LMP1 oncogene deletions in Burkitt's lymphoma from Pakistan: Epidemiological correlations. Hum. Pathol. 1997; 28: 283–288
   PubMed Web of Science ®Google Scholar
• Chang K. L., Albujar P. F., Chen Y.-Y., Johnson R. M., Weiss L. M. High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of Hodgkin's disease occurring in Peru. Blood 1993; 81: 496–501
   PubMed Web of Science ®Google Scholar
• Ambinder R. F., Browning P. J., Lorenzana I., et al. Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United States. Blood 1993; 81: 462–467
   PubMed Web of Science ®Google Scholar
• Gulley M. L., Eagan P. A., Quintanilla-MartÍNez L., El al. Epstein-Barr virus DNA is abundant and monoclonal in the Reed-Sternberg cells of Hodgkin's disease: association with mixed cellularity subtype and hispanic American ethnicity. Blood 1994; 83: 1595–1602
   PubMed Web of Science ®Google Scholar
• Quintanilla-martínez L., Gamboa-DomÍNguez A., Gamez-Ledesma I., Angeles-Angeles A., Mohar A. Association of Epstein-Barr virus latent membrane protein and Hodgkin's disease in Mexico. Mod. Pathol. 1995; 8: 675–679
   PubMed Web of Science ®Google Scholar
• Jaffe E. S., Chan J. K. C., Su I.-J., et al. Report of the workshop on nasal and related extranodal angiocentric T/Natural killer cell lymphomas. Am. J. Surg. Pathol. 1996; 20: 103–111
   PubMed Web of Science ®Google Scholar
• Arista-Nasr J., Gonzalez-Romo M. A., Mantilla-Morales A., Lazos-Ochoa M., Ortiz-Hidalgo C. Immunoproliferative small intestinal disease in Mexico. Report of four cases and review of the literature. J. Clin. Gastroenterol. 1994; 18: 67–71
   PubMed Web of Science ®Google Scholar
• Domizio P., Owen R. A., Shepherd N. A., Talbot I. C., Norton A. J. Primary lymphoma of the small intestine. A clinicopathologic study of 119 cases. Am. J. Surg. Pathol. 1993; 17: 429–442
   PubMed Web of Science ®Google Scholar
• Anagnostopoulos I., Hummel M., Stein H. Frequent presence of latent Epstein-Barr virus infection in peripheral T-cell lymphomas. A Review. Leukem. Lymphoma 1995; 19: 1–12
   PubMed Web of Science ®Google Scholar
• De Bruin P. C., Jiwa N. M., Oudejans J. J., Radaszkiewicz T., Meyer C. J. L. M. Epstein-Barr virus in primary gastrointestinal T cell lymphomas. Association with gluten-sensitive enteropathy, pathological features, and immunophenotype. Am. J. Pathol. 1995; 146: 861–867
   PubMed Web of Science ®Google Scholar
• Ilyas M., Niedobitek G., Agathanggelou A., et al. Non-Hodgkin's lymphoma, coeliac disease, and Epstein-Barr virus: a study of 13 cases of enteropathy-associated T-and B-cell lymphoma. J. Pathol. 1995; 177: 115–122
   PubMed Web of Science ®Google Scholar
• Lee S. S., Jang J. J., Cho K. J., Khang S. K., Kim C. W. Epstein-Barr virus-associated primary gastrointestinal lymphoma in non-immunocompromised patients in Korea. Histopathology 1997; 30: 234–242
   PubMed Web of Science ®Google Scholar
• Ott G., Ott M. M., Feller A. C., Seidl S., Müller-hermelink H.-K. Prevalence of Epstein-Barr virus DNA in different T-cell lymphoma entities in a european population. Int. J. Cancer 1992; 51: 562–567
   PubMed Web of Science ®Google Scholar
• Ott G., Kirchner T., Seidl S., MÜLler-Hermelink H.-K. Primary gastric lymphoma is rarely associated with Epstein-Barr virus. Virchows. Arch. B Cell. Pathol. 1993; 64: 287–294
   Google Scholar
• Pan L., Diss T. C., Peng H., et al. Epstein-Barr virus (EBV) in enteropathy-associated T-cell lymphoma (EATL). J. Pathol. 1993; 170: 137–143
   PubMed Web of Science ®Google Scholar
• Quintanilla-martínez L., Lome-Maldonado C., Ott G., et al. Primary non-Hodgkin's lymphoma of the intestine: high prevalence of Epstein-Barr virus in Mexican lymphomas as compared with European cases. Blood 1997; 89: 644–651
   PubMed Web of Science ®Google Scholar
• Walsh S. V., Egan L. J., Connolly C. E., Stevens F. M., Egan E. L., McCarthy C. F. Enteropathy-associated T-cell lymphoma in the west of Ireland: low-frequency of Epstein-Barr virus in these tumors. Mod. Pathol. 1995; 8: 753–757
   PubMed Web of Science ®Google Scholar
• Griesser H., Henry M., Boie C., Banerjee D. Large-cell anaplastic lymphoma of the gastrointestinal tract: an immuno-and genotypic study on archival material. Hematol. Pathol. 1994; 8: 121–134
   PubMedGoogle Scholar
• Chott A., Dragosics B., Radaszkiewicz T. Peripheral T-cell lymphomas of the intestine. Am. J. Pathol. 1992; 141: 1361–1371
   PubMed Web of Science ®Google Scholar
• Hsiao C.-H., Lee W.-L., Chang S.-L., Su I.-J. Angiocentric T-cell lymphoma of the intestine: a distinct etiology of ischemic bowel disease. Gastroenterology 1996; 110: 985–990
   PubMed Web of Science ®Google Scholar
• Chan J. K. C., Sin V. C., Wong K. F., et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of an uncommon aggressive neoplasm. Blood 1997; 89: 4501–4513
   PubMed Web of Science ®Google Scholar
• Jaffe E. S. Classification of natural killer (NK) cell and NK-like T-cell malignancies. Blood 1996; 87: 1207–1210
   PubMed Web of Science ®Google Scholar
• Kobashi Y., Nakamura S., Sasajima Y., et al. Inconsistent association of Epstein-Barr virus with CD56 (NCAM)-positive angiocentric lympoma occuring in sites other than the upper and lower respiratory tract. Histopathology 1996; 28: 111–120
   PubMed Web of Science ®Google Scholar
• Nakamura S., Suchi T., Koshikawa T., et al. Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. Am. J. Surg. Pathol. 1995; 19: 284–296
   PubMed Web of Science ®Google Scholar
• Tsang W. Y. W., Chan J. K. C., Yip T. T. C., et al. In situ localization of Epstein-Barr virus encoded RNA in non-nasal/nasopharyngeal CD56-positive and CD56-negative T-cell lymphomas. Hum. Pathol. 1994; 25: 758–765
   PubMed Web of Science ®Google Scholar
• Felgar R. E., Macon W. R., Kinney M. C., Roberts S., Pasha T., Salhany K. E. TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T-lymphocyte or natural killer cell differentiation. Am. J. Pathol. 1997; 150: 1893–1900
   PubMed Web of Science ®Google Scholar
• Mathus-Vliegen E. M. H., Van Halteren H., Tytgat G. N. J. Malignant lymphoma in coeliac disease: various manifestations with distinct symptomatology and prognosis?. J. Intern. Med. 1994; 236: 43–49
   PubMed Web of Science ®Google Scholar
• Ambinder R. F., Mann R. B. Detection and characterization of Epstein-Barr virus in clinical specimens. Am. J. Pathol. 1994; 145: 239–252
   PubMed Web of Science ®Google Scholar
• Chen C.-L., Sadler R. H., Walling D. M., Su I.-J., Hsieh H.-C., Raab-Traub N. Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas. J. Virol 1993; 67: 6303–6308
   PubMed Web of Science ®Google Scholar
• Suzushima H., Asou N., Fujimoto T., et al. Lack of the expression on EBNA-2 and LMP-1 in T-cell neoplasms possessing Epstein-Barr virus. Blood 1995; 85: 480–486
   PubMed Web of Science ®Google Scholar
• Ohshima K., Kikuchi M., Eguchi F., et al. Analysis of Epstein-Barr viral genomes in lymphoid malignancy using Southern blotting, polymerase chain reaction and in situ hybridization. Virchows Arch. B (Cell. Pathol.) 1990; 59: 383–390
   Google Scholar
• Fend F., Hittmair A., Rogatsch H., Gredler E., Obrist P., Mikuz G. Seminomas positive for Epstein-Barr virus by the polymerase chain reaction: viral RNA transcripts (EBERs) are present in intratumoral lymphocytes, but absent from the neoplastic cells. Mod. Pathol. 1995; 8: 622–625
   PubMed Web of Science ®Google Scholar
• Niedobitek G., Herbst H., Young L. S., et al. Patterns of Epstein-Barr virus infections in non-neoplastic lymphoid tissue. Blood 1992; 79: 2520–2526
   PubMed Web of Science ®Google Scholar
• Sandlund J. T., Fonseca T., Leimig T., et al. Predominance and characteristics of Burkitt lymphoma among children with non-Hodgkin lymphoma in northeastern Brazil. Leukemia 1997; 11: 743–746
   PubMed Web of Science ®Google Scholar
• Isaacson P. G. Intestinal lymphoma and enteropathy. J. Pathol. 1995; 177: 111–113
   PubMed Web of Science ®Google Scholar
• Mäki M., Collin P. Coeliac disease. Lancet 1997; 349: 1755–1759
   PubMed Web of Science ®Google Scholar
• Spencer J., Cerf-Bensusson N., Jarry A., et al. Enteropathy-associated T-cell lymphoma (malignant histiocytosis of the intestine) is recognized by a monoclonal antibody (HML-1) that defines a membrane molecule on human mucosal lymphocytes. Am. J. Pathol. 1988; 132: 1–5
   PubMed Web of Science ®Google Scholar
• Borisch B., Hennig I., Horber F., Burki K., Laissue J. Enteropathy-associated T-cell lymphoma in a renal transplant patient with evidence of Epstein-Barr virus involvement. Virchows Arch. A (Pathol. Anat. Histopathol.) 1992; 421: 443–447
   PubMedGoogle Scholar
• Kern W. F., Spier C. M., Hanneman E. H., Miller T. P., Matzner M., Grogan T. M. Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement. Blood 1992; 79: 2432–2437
   PubMed Web of Science ®Google Scholar
• Martin A. R., Chan W. C., Perry D. A., Greiner T. C., Weisenburger D. D. Aggressive natural killer cell lymphoma of the small intestine. Mod. Pathol. 1995; 8: 467–472
   PubMed Web of Science ®Google Scholar
• Navarro-Roman L., Zarate-Osorno A., Meneses A., Kingma D. W., Jaffe E. S. High grade AIL and Epstein-Barr virus infection in 22 cases from Mexico. Mod. Pathol. 1994; 7: 151A
   Google Scholar
• Boyle M. J., Sewell W. A., Sculley T. B., et al. Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin lymphoma. Blood 1991; 78: 3004–3010
   PubMed Web of Science ®Google Scholar
• Zimber U., Adldinger H. K., Lenoir G. M., et al. Geographical prevalence of two types of Epstein-Barr virus. Virology 1986; 154: 56–66
   PubMed Web of Science ®Google Scholar
• Chen M. L., Tsai C. N., Liang C. L., et al. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr variant derived from the nasopharyngeal carcinoma in the Tawainese population. Oncogene 1992; 7: 2131–2140
   PubMed Web of Science ®Google Scholar
• Sandvej K., Peh S. C., Andresen B. S., Pallesen G. Identification of potential hot spots in the carboxyl-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV associated diseases: High frequency of a 30-bp deletion in Malasyan and Danish peripheral T-cell lymphomas. Blood 1994; 84: 4053
   PubMed Web of Science ®Google Scholar
• Kingma D. W., Weiss W. B., Jaffe E. S., Kumar S., Frekko K., Raffeld M. Epstein-Barr virus latent membrane protein-1 oncogene deletions: Correlations with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas. Blood 1996; 88: 242–251
   PubMed Web of Science ®Google Scholar
• Knecht H., Bachmann E., Brousset P., et al. Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood 1993; 82: 2937–2942
   PubMed Web of Science ®Google Scholar
• Knecht H., RaphaËL M., McQuain C., et al. Deletion variants within the NF-kB avtivation domain of the LMP1 oncogene prevail in acquired immunodeficiency syndrome-related large cell lymphomas and human immunodeficiency virus-negative atypical lymphoproliferations. Blood 1996; 87: 876–881
   PubMed Web of Science ®Google Scholar
• Khanim F., Yao Q.-Y., Niedobitek G., Sihota S., Rickinson A. B., Young L. S. Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations. Blood 1996; 88: 3491–3501
   PubMed Web of Science ®Google Scholar
• Elenitoba-Johnson K. S. J., Zarate-Osomo A., Meneses A., et al. EBV strain type and LMP-1 oncogene deletions in nasal T/NK-cell lymphomas from Mexico. Lab. Invest. 1997; 76: 124A
   Google Scholar
• Pathmanathan R., Prasad U., Sadler R., Flynn K., Raab-Traub N. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N. Engl. J. Med. 1995; 333: 693–698
   PubMed Web of Science ®Google Scholar